ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Personalized Approach in the Diagnostic and Treatment of Tinnitus| Biomed Grid

Journal: American Journal of Biomedical Science & Research (Vol.3, No. 5)

Publication Date:

Authors : ; ;

Page : 439-441

Keywords : Tinnitus; Hearing threshold; Distortion product otoacoustic emissions (DPOAE); Transient otoacoustic emissions (TEOAE); Pure-Tone Audiometry (PTA); Auditory Brainstem Response (ABR); Biomed Grid;

Source : Downloadexternal Find it from : Google Scholarexternal


Tinnitus is a disease that affects millions of people. However, there is still no standard for diagnosing and treating this disease. What necessitates a lot of new research in this area? The object: 40 patients with Tinnitus studied at Audiology department of the State Institution “The Republican Center for Research and Practice in Otolaryngology”, from 2018 to 2019 year. The aim: To determine the most effective method of management patients with Tinnitus. The methodology: Mathematical statistics, Student t-test, Fisher test. All patients underwent DPOAE, TEOAE, tympanometry and acoustic reflexes, Auditory Brainstem Response, high-frequency audiometry, Word Recognition test. The results: The study involved 40 individuals an equal man (N=23) and women (N=17) in the middle age at 32,31 ± 10 years (95% CI 18- 55 years). All patients (N=40) were divided into 2 groups: 1 group (соntrol) - patients with tinnitus with standard diagnostic and treatment plus white noise masking, 2 group (experience) –patients with tinnitus who were managed with personalized approach. It was found that statistically significant difference was observed between the both groups diagnosed with DPOAE and TEOAE. All patients successfully passed the TEOAE-test from 2 groups. But all patients showed lower results at 1501, 2002, 6000, 8000 Hz frequencies by the distortion-product otoacoustic emissions. It was significantly revealed an elongation or the shortening of the peak of I wave (t≥ 0,95) with an increase in the amplitude and an increase in the latency. Speech intelligibility was 80±5% (t≥ 0,95in both groups. Based on the characteristics of the peak of I wave, drug treatment was prescribed to stimulate or inhibit the functioning of the auditory nerve in the experience group for 2 weeks. Additionally, in the group of experience group, listening to delta waves at a frequency of 5kHz was assigned for three months. Significant difference was achieved in the experiment group and was accompanied by the restoration of the amplitude of the peak of I wave to 61,3 ± 5.8 % to normal and completely passing DPOEA during 6 months.

Last modified: 2019-07-10 13:49:56